This program is part of a national training initiative, which has been endorsed by the Federal Center for Substance Abuse Treatment (CSAT) and is sponsored by the American Osteopathic Academy of Addiction Medicine. Physicians who successfully complete this 8 hour-course will be eligible to request a waiver to practice medical-assisted addiction therapy with Buprenorphine, for the treatment of opioid dependence. PCSS-MAT is a collaborative project with the American Osteopathic Academy of Addiction Medicine (AOAAM), American Academy of Addiction Psychiatry (AAAP), American Psychiatric Association (APA), American Society of Addiction Medicine (ASAM) and Association for Medical Education and Research in Substance Abuse (AMERSA). PCSS-MAT’s mission is to provide free, evidence-based resources to train clinicians and the public about the effectiveness of medications used for treating opioid addiction, including buprenorphine, naltrexone and methadone, in order to more effectively address this public health crisis.
The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine.
Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. Phone attendance only does NOT qualify for webinar participation. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law.
CONTINUING MEDICAL EDUCATION:
This program has been approved for 4.0 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.0 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session and participate in the polling questions and post-test (with a passing grade of 70%) in order to be eligible for CME credit.
For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssmat.org.
Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (1U79TI026556) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.